Very few of us here have actual clinical research experience (ie., drug development), it is extremely rigourous to get thru Phase I, II, III clinical trials...For a REASON!!! Demonstration of Safety and Efficacy must be both clinical and statistical, that is why I really have a very difficult time with docs charging the study subject for treatments which have at best in vitro or anectdotal evidence (e.g., PRP).
HM needs another 10-15 years of development and probably an infusion of over a billion dollars or more of investment money before it has a chance of reaching the market.
I did not say the Study Subject pays the BILLION dollars, that is the risk of the investor.